Stanford's Dr Crystal Mackall on the Evolution of and Future Directions in Cell Therapy

https://is1-ssl.mzstatic.com/image/thumb/Podcasts221/v4/d0/cb/0d/d0cb0de6-ff12-70cd-fba5-6720111b2cf4/mza_5543077143899086824.jpg/600x600bb.jpg

PharmaTalkRadio

Conference Forum

513 episodes

1 week ago

PharmaTalkRadio is an internet radio podcast platform organized and supported by the Conference Forum to give easy and free access to industry professionals, patient advocacy and students in medicine development. PharmaTalkRadio features industry insiders on the latest strategies, business models, and new innovations to advance clinical research with emphasis on clinical trials, patient- centricity, drug delivery, Immuno-oncology, digital, mobile and other technologies as well as leadership topics and emerging biotech challenges. Also featured on PharmaTalkRadio are podcasts covering a wide range of topics from Conference Forum events.

All content for PharmaTalkRadio is the property of Conference Forum and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.

Stanford's Dr Crystal Mackall on the Evolution of and Future Directions in Cell Therapy

PharmaTalkRadio

28 minutes

2 months ago

Stanford's Dr Crystal Mackall on the Evolution of and Future Directions in Cell Therapy

About this podcast:
Recorded at the 2025 Immuno-Oncology 360º Summit, Stanford University's Dr Crystal Mackall shares work from her lab developing GD2-targeting CAR T cell therapy for the treatment of deadly pediatric brain tumor, as well as broader lessons on the evolution of cell therapy, and her forward-looking perspective on shaping the next generation of cancer treatments.

For more information, go to IO360summit.com.